Vanguard Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Other funds holding MDGL
BBA
Vanguard Asset Management's MDGL Position: Q3 2026 in Review
Vanguard Asset Management increased its Madrigal Pharmaceuticals (MDGL) stake by 6% in Q3 2026, buying an estimated $483K and bringing the position to 16,117 shares worth $8.12M. The position accounts for 0.01% of the portfolio, ranked #805.
Vanguard Asset Management first reported a position in MDGL in Q1 2026 and has held it in 3 quarters since. The position peaked at $8.16M in Q2 2026. 441 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.
- Vanguard Asset Management held 16,117 shares of Madrigal Pharmaceuticals worth $8.12M as of Q3 2026.
- Vanguard Asset Management bought 913 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $483K.
- Madrigal Pharmaceuticals made up 0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #805 holding.
- Vanguard Asset Management first reported a position in Madrigal Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- Vanguard Asset Management's Madrigal Pharmaceuticals position peaked at $8.16M in Q2 2026.
- 441 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.
Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.